| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73d55b44219a84c850812a4488def924 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70532 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6841
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6841
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate |
2019-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d69a1a4585d3fda88be08d5928886be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d9373919ff67eed356cfacd8ea8bed2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0f1920170f5b61eeaaa0e6e3a1e854d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14c5e2c98fdde580bb36578c2f57ee83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe1d6ed808b44c47b4d3df1e8053cc9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3396b617ea1496fc2472cf51ef68790 |
| publicationDate |
2019-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019159825-A1 |
| titleOfInvention |
Biomarker for predicting effects of anti-pd-1 antibody/anti-pd-l1 antibody therapy |
| abstract |
The purpose of the present invention is to provide: a novel marker capable of predicting the effects of anti-PD-1 antibody/anti-PD-L1 antibody therapy with high sensitivity; and a use thereof. Provided is a biomarker for predicting the effects of anti-PD-1 antibody/anti-PD-L1 antibody therapy, the biomarker comprising the immunoglobulin superfamily containing a leucine-rich repeat (ISLR). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021157601-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021210416-A1 |
| priorityDate |
2018-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |